Depersonalization Disorder Clinical Trial
Official title:
Depersonalization Disorder: Therapeutic Effect of Neuronavigated Repetitive Transcranial Stimulation of Right Angular Gyrus.
The purpose of this study is to assess the therapeutic efficacy of transcranial magnetic stimulation in patients with depersonalization disorder.
Depersonalization disorder is characterised by a profound disruption of self-awareness. Depersonalization symptoms may occasionally arise (30 to 70% of the population) or may become chronic in depersonalization disorder. Its prevalence is around 2.4% in the general population. This disorder is particularly resistant to pharmacological treatments. This study is a randomized, double-blind, placebo-controlled study, and the investigators are testing the therapeutic efficacy of neuronavigated repetitive Transcranial Magnetic Stimulation (TMS) of right angular gyrus in patients with depersonalization disorder. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02256085 -
Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation (rTMS)
|
Phase 2 | |
| Completed |
NCT00529217 -
Treatment of Depersonalization Disorder With Transcranial Magnetic Stimulation (TMS)
|
Phase 2 | |
| Completed |
NCT00004446 -
Study of Fluoxetine in Patients With Depersonalization Disorder
|
N/A |